Avia Pharma has signed a long-term license agreement with Endoceutics for the Nordic commercial rights to Intrarosa®. Intrarosa® is locally administered for the treatment of vaginal atrophy. Intrarosa® contains prasterone, an inactive steroid hormone that is converted locally inside the vaginal cells into androgens and estrogens. This intracellular production does…
Avia Pharma appoints Mattias Wik as Business Unit Director Oncology/Urology
Avia Pharma appoints Mattias Wik as Business Unit Director Oncology/Urology. Mattias Wik has 20 years of experience from the pharmaceutical industry, working at AMGEN in various positions. “Mattias brings a lot of experience to Avia Pharma and with a proven track record in launching products on the Nordic market, will…
Parents prepared to pay out of pocket for vitamin D without palm oil
Currently there are two Vitamin D drops being sold on the Swedish market. ACO Vitamin D drops does not contain palm oil but the competing product does. Vitamin D drops is given to children up to the age of 2 and in some cases up to the age of 5.…
License agreement signed for Vectavir, Vectatone and Silence
Following a very strong sales increase for all products, Omega Pharma and Avia Pharma has decided to expand their co-operation. From January 1st 2018 Avia Pharma will handle all commercial aspects of Vectavir, Vectatone and Silence in the Nordics. “Avia Pharma is proud of the trust Omega Pharma has put…
Avia Pharma appoints Marie Wikman as Business Unit Director OTC
Avia Pharma appoints Marie Wikman as Business Unit Director OTC. Marie Wikman has been working her whole career building strong brands and categories. She has held positions at Cloetta, Carlsberg, Mediacom and during the last 5 years at Apoteket AB. “Marie understands both the needs of the pharmacy category organizations…
Long term license agreement signed for Spasmex and Vagitin
Avia Pharma and Dr Pfleger have entered into a long-term license agreement for Spasmex (Trospium) and Vagitin (Nystatin). The license for Spasmex covers Sweden and Norway and the license for Vagitin covers all Nordic countries. Spasmex is a well-known product for over-active bladder and is sold in many European countries.…
ACO vitamin D now without palm oil
The Swedish MPA has approved a new formulation of ACO Vitamin D without palm oil. Palm oil has negative impact on the environment and the Swedish Food agency recommends parents not to give their children any food products containing palm oil. ACO Vitamin D drops is the only pharmaceutical without…
New design and pack size for Duroferon
Avia Pharma has developed a more contemporary package for Duroferon on the Swedish market. The new design affects the 100-tablet blister, the 200-tablet blister and the 100-tablet plastic container. A 60-tablet blister pack has also been introduced on the market. “We are continuously investing in our products and this is…
Avia Pharma appoints Jonas Karlander as CFO
Avia Pharma appoints Jonas Karlander as CFO. Jonas Karlander has for the last 20 years been working in different controlling and finance positions in multiple industries. “We are very pleased that Jonas Karlander has decided to join Avia Pharma. He will strengthen our capabilities, not only in controlling/finance, but also…
SLL updates treatment guidelines for iron supplements
The new “Kloka Listan” from SLL has updated its recommendation for iron supplements. It previously stated, incorrectly, that Niferex had fewer adverse events than Duroferon. An analysis of reported adverse events and sales data showed that Niferex had 17% more reported adverse events than Duroferon. The new text recommends Duroferon…